Coly-Mycin M Parenteral 150mg is an antibiotic medication used for the treatment of bacterial infections caused by susceptible strains of gram-negative organisms. It contains colistimethate, which belongs to the class of polymyxin antibiotics and works by disrupting the cell membrane of bacteria, leading to their death.

This medication is commonly used for the treatment of respiratory tract infections, including pneumonia and bronchitis caused by bacteria such as Pseudomonas aeruginosa, Acinetobacter species, and Klebsiella species. It is also used to treat infections of the bladder, urinary tract, and skin caused by these bacteria.

Additionally, Coly-Mycin M Parenteral may be used as a prophylactic treatment for individuals who are at an increased risk for developing bacterial infections, such as patients with cystic fibrosis or those undergoing certain types of surgeries or medical procedures.

It is important to note that this medication is only effective against bacterial infections and will not work for viral infections such as the common cold or flu. It should only be used as prescribed by a healthcare professional. 

Coly-Mycin M Parenteral is an antibiotic medication used to treat serious bacterial infections caused by susceptible strains of bacteria. It is commonly used to treat infections of the respiratory tract, urinary tract, skin, and soft tissue. It is also used to prevent infection in certain surgical procedures.

Synonyms Coly-Mycin® M Parenteral (sterile colismethate sodium, USP); Sodium colistin methanesulfonate
Trade names Coly-Mycin® M Parenteral
Chemical family Polypeptide; lyophilized
Relevant identified uses of the substance or
mixture and uses
advised against
Bulk formulated pharmaceutical product/ Formulated pharmaceutical product
packaged in final form for patient use. Used for the treatment of infections.